Please provide your email address to receive an email when new articles are posted on . IntraFuse announced the United States Patent and Trademark office has granted ...
To determine if use of an osteogenic agent (rhBMP-2) at the time of surgical treatment for tibial pseudarthosis in NF1 patients will result in improved bone healing when compared to NF1 patients ...
SOLOTHURN, Switzerland--(BUSINESS WIRE)--DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced the availability of Expert Tibial Nail PROtect, the only tibial nail with a ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果